2023
DOI: 10.1002/hed.27540
|View full text |Cite
|
Sign up to set email alerts
|

TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas

Yuki Saito,
Hidenori Kage,
Kenya Kobayashi
et al.

Abstract: BackgroundsThe importance of TERT promoter (pTERT) mutation of oral cavity squamous cell carcinoma (OCSCC) with clinical features and genetic alterations are not well recognized.MethodsWe retrospectively analyzed genetic data from multiple databases, including 260 cases from the C‐CAT database, 407 cases from the MSK‐MetTropism database, and 40 OCSCC datasets from in‐house clinical samples.ResultsFrom C‐CAT database, TP53 (66%), CDKN2A (51%), and pTERT (29%) were the most frequent mutations observed. pTERT mut… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Post-transcriptional regulation includes miRNA-mediated processes, where dysregulation of microRNAs targeting TERT may lead to increased mRNA stabilization and elevated TERT expression in OSCC. The complex interplay of these mechanisms underscores the diverse and signi cant role of TERT in OSCC development and progression [116,117].…”
Section: Role Of Tert In Oral Squamous Cell Carcinoma (Oscc)mentioning
confidence: 99%
“…Post-transcriptional regulation includes miRNA-mediated processes, where dysregulation of microRNAs targeting TERT may lead to increased mRNA stabilization and elevated TERT expression in OSCC. The complex interplay of these mechanisms underscores the diverse and signi cant role of TERT in OSCC development and progression [116,117].…”
Section: Role Of Tert In Oral Squamous Cell Carcinoma (Oscc)mentioning
confidence: 99%
“… 7 Mutations or deletions within this gene have been linked to numerous cancers, establishing its significance as a critical oncogene. Recent literature 8 , 9 , 10 indicates that while apoptosis induction remains a common chemotherapeutic action mechanism, primary apoptosis regulators, notably p53 and p16/CDKN2A, are often inactivated within tumour tissues, which can lead to resistance against such treatments.…”
Section: Introductionmentioning
confidence: 99%